• Japanese
  • Korean
  • Chinese
Cover Image

Global Active Pharmaceutical Ingredients Market 2011-2015

Abstract

TechNavio's analysts forecast the Global Active Pharmaceutical Ingredient market to grow at a CAGR of 7.9 percent over the period 2011-2015. One of the key factors contributing to this market growth is the entry of novel formulation technologies. The Global Active Pharmaceutical Ingredient market has also been witnessing the trend of increasing outsourcing of API manufacturing to China and India. However, the stringent regulatory environment could pose a challenge to the growth of this market.

TechNavio's report, the Global Active Pharmaceutical Ingredient Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Active Pharmaceutical Ingredient market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this market space include Lonza Group Ltd., Boehringer Ingelheim GmbH, Royal DSM N.V. and BASF SE.

Other vendors mentioned in the report are Bayer AG, Merck & Co., Mylan Inc., Hospira Inc., GlaxoSmithKline plc, Pfizer Inc., Eli Lilly and Co., Sanofi S.A., Zhejiang Hisun Pharmaceutical Co. Ltd., Ranbaxy Laboratories Ltd., Dr. Reddy's Laboratories Ltd., Watson Pharmaceuticals Inc. and Teva Pharmaceuticals Industries Ltd.

Key questions answered in this report:

  • What will the market size be in 2015 and at what rate will it grow?
  • What key trends is this market subject to?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the opportunities and threats faced by each of these key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of analyst time when you purchase this report. Details provided within the report.

Table of Contents

01. Executive Summary

02. Introduction

03. Market Coverage

  • Market Overview
  • Product Offerings

04. Market Landscape

  • 04.1. Global Active Pharmaceutical Ingredients Market
    • Market Size and Forecast
    • Market Segmentation
    • Market Share of Market Segments by Type of Synthesis
    • Forecast of Market Share of Market Segments by Type of Synthesis
    • Sub-segmentation of Biotech API Segment
  • 04.2. Global Biotech Active Pharmaceutical Ingredients Market
    • Market Size and Forecast
  • 04.3. Global Synthetic Active Pharmaceutical Ingredients Market
    • Market Size and Forecast
  • 04.4. Global High Potency Active Pharmaceutical Ingredients Market
    • Market Size and Forecast
    • Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Type of Synthesis
    • Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Customer Base
  • 04.5. Five Forces Analysis

05. Geographical Segmentation

06. Key Leading Countries

  • USA
  • Japan
  • China
  • Economic Indicators of Key Leading Countries

07. Vendor Landscape

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis

  • 14.1. Lonza Group Ltd.
    • Business Overview
    • SWOT Analysis
  • 14.2. Boehringer Ingelheim GmbH
    • Business Overview
    • SWOT Analysis
  • 14.3. Royal DSM N.V.
    • Business Overview
    • SWOT Analysis
  • 14.4. BASF SE
    • Business Overview
    • SWOT Analysis

15. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Global Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
  • Exhibit 2: Market Segmentation by Type of Synthesis
  • Exhibit 3: Market Segmentation by Type of Technology
  • Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011
  • Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011-2015 (percentage)
  • Exhibit 6: Biotech Active Pharmaceutical Ingredients Segment Sub-segmentation 2011
  • Exhibit 7: Global Biotech Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
  • Exhibit 8: Global Synthetic Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
  • Exhibit 9: Global High Potency Active Pharmaceutical Ingredients Market 2011-2015 (US$ billion)
  • Exhibit 10: Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Type of Synthesis
  • Exhibit 11: Global High Potency Active Pharmaceutical Ingredients Market Segmentation by Type of Synthesis 2011
  • Exhibit 12: Global High Potency Active Pharmaceutical Ingredients Market Segmentation Based on Customer Base
  • Exhibit 13: Global High Potency Active Pharmaceutical Ingredients Market Segmentation by Customer Base 2011
  • Exhibit 14: Global Active Pharmaceutical Ingredients Market by Geographical Segmentation 2011
Show More
RELATED REPORTS
* Analyzing the Global Market for Active Pharmaceutical Ingredients
  • Published:
  • Oct 01, 2013
  • USD 1250
  • 364 Pages

* Active Pharmaceutical Ingredients (API) Global Market to 2017 - Growth in Developing Markets to Come From Cost Efficient Manufacturing and Rising Domestic Demand
  • Published:
  • Nov 09, 2012
  • USD 3500
  • 221 Pages

* Active Pharmaceutical Ingredients (APIs) Market in Asia Pacific to 2017 - Increasing Penetration in China and India Coupled with Low Cost Manufacturing to Fuel Regional Growth
  • Published:
  • Nov 09, 2012
  • USD 3500
  • 95 Pages

* High Potency Active Pharmaceutical Ingredients (HPAPIs) Market - Global Industry Analysis, Size, Growth, Share And Forecast, 2012 - 2018
  • Published:
  • Oct 31, 2012
  • USD 4595
  • 110 Pages

* Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
  • Published:
  • Aug 22, 2012
  • USD 3500
  • 85 Pages

* Analysis of the Active Pharmaceutical Ingredients Market
  • Published:
  • Jul 23, 2012
  • USD 6000

* Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
  • Published:
  • Jul 10, 2012
  • USD 3500
  • 105 Pages

* Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016)
  • Published:
  • Dec 06, 2011
  • USD 5650
  • 345 Pages

* Active Pharmaceutical Ingredients (APIs) Market to 2015 - Rise in the Generic and Biotech Sector will Sustain Growth
  • Published:
  • Oct 01, 2010
  • USD 3500
  • 114 Pages

* The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity
  • Published:
  • Mar 15, 2010
  • USD 3500
  • 54 Pages

Browse more Pharmaceutical Market Research Reports

Pricing
Get Notified
Email me when related reports are published